Vontobel Holding
RXRX icon

Vontobel Holding’s Recursion Pharmaceuticals RXRX Stock Holding History

Vontobel Holding’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.7K Buy
21,725
+10,125
+87% +$33.7K ﹤0.01% 1423
2026
Q1 		$35.6K Buy
11,600
+200
+2% +$773 ﹤0.01% 1179
2025
Q4 		$46.6K Hold
11,400
– – ﹤0.01% 1407
2025
Q3 		$55.6K Sell
11,400
-400
-3% -$2.1K ﹤0.01% 1320
2025
Q2 		$59.7K Hold
11,800
– – ﹤0.01% 1224
2025
Q1 		$62.4K Buy
11,800
+1,200
+11% +$8.75K ﹤0.01% 1057
2024
Q4 		$71.7K Hold
10,600
– – ﹤0.01% 1055
2024
Q3 		$69.9K Buy
+10,600
New +$76K ﹤0.01% 1048

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vontobel Holding's RXRX Position: Q2 2026 in Review

Vontobel Holding increased its Recursion Pharmaceuticals (RXRX) stake by 87% in Q2 2026, buying an estimated $33.7K and bringing the position to 21,725 shares worth $79.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Vontobel Holding first reported a position in RXRX in Q3 2024 and has held it in 8 quarters since. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Vontobel Holding held 21,725 shares of Recursion Pharmaceuticals worth $79.7K as of Q2 2026.
  • Vontobel Holding bought 10,125 Recursion Pharmaceuticals shares in Q2 2026, an estimated $33.7K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1423 holding.
  • Vontobel Holding first reported a position in Recursion Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.